Adimmune Corporation

Adimmune Corporation - PE Ratioverified

4142.TW

Price:

$17.25

Market Cap:

$7.27B

Adimmune Corporation, a Taiwanese pharmaceutical company, specializes in the production and distribution of human vaccines. Its comprehensive product portfolio includes a range of critical immunizations. Key offerings feature the quadrivalent influenza vaccine, AdimFlu-S, alongside trivalent influenza vaccines and the Influenza A (H1N1) Virus Monovalent Vaccine. The company also provides tetanus toxoid products, vital for post-injury tetanus prevention, and Japanese encephalitis vaccines. Furthermore, Adimmune supplies purified Tuberculin and extends its expertise through contract manufacturing services. Established in 1965, the company initially operated under the name Kuo Kwang Serum and V...[Read more]

Industry

Biotechnology

IPO Date

2012-05-03

Stock Exchange

TAI

Ticker

4142.TW

The PE Ratio as of August 2026 (TTM) for Adimmune Corporation (4142.TW) is -35.20

According to Adimmune Corporation’s latest financial reports and current stock price. The company's current PE Ratio is -35.20. This represents a change of 7.21% compared to the average of -32.83 of the last 4 quarters.

Adimmune Corporation (4142.TW) Historical PE Ratio (quarterly & annually)

How has 4142.TW PE Ratio performed in the past?

The mean historical PE Ratio of Adimmune Corporation over the last ten years is 37.24. The current -35.20 PE Ratio has changed -9553.41% with respect to the historical average. Over the past ten years (40 quarters), 4142.TW's PE Ratio was at its highest in in the June 2022 quarter at 88.86. The PE Ratio was at its lowest in in the September 2018 quarter at -181.56.

Quarterly (TTM)
Annual

Average

37.24

Median

-8.12

Minimum

-34.66

Maximum

446.50

Adimmune Corporation (4142.TW) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Adimmune Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 2.31%

Maximum Annual PE Ratio = 446.50

Minimum Annual Increase = -156.35%

Minimum Annual PE Ratio = -34.66

Quarterly (TTM)
Annual
YearPE RatioChange
2025-33.25-4.07%
2024-34.6658.90%
2023-21.81-141.66%
202252.35-88.27%
2021446.502.31%
202018.51-156.35%
2019-32.86353.39%
2018-7.2516.88%
2017-6.20-31.12%
2016-9.0017.04%

Adimmune Corporation (4142.TW) Average PE Ratio

How has 4142.TW PE Ratio performed in the past?

The current PE Ratio of Adimmune Corporation (4142.TW) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-29.90

5-year avg

81.83

10-year avg

37.24

Adimmune Corporation (4142.TW) PE Ratio vs. Peers

How is 4142.TW’s PE Ratio compared to its peers?

Adimmune Corporation’s PE Ratio is greater than CHO Pharma, Inc. (-85.56), less than TaiGen Biopharmaceuticals Holdings Limited (113.39), less than Mycenax Biotech Inc. (-11.75), less than Pharmosa Biopharm Inc. (-10.75), less than Acepodia, Inc. (-8.88), less than AP Biosciences Inc (-19.79), less than OBI Pharma, Inc. (-0.85), greater than BioGend Therapeutics Co., Ltd. (-47.41), less than Sinphar Pharmaceutical Co. Ltd. (18.11), less than PharmaEngine, Inc. (21.39),

Build a custom stock screener for Adimmune Corporation (4142.TW) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Adimmune Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Adimmune Corporation (4142.TW) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Adimmune Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Adimmune Corporation's PE Ratio?

How is the PE Ratio calculated for Adimmune Corporation (4142.TW)?

What is the highest PE Ratio for Adimmune Corporation (4142.TW)?

What is the 3-year average PE Ratio for Adimmune Corporation (4142.TW)?

What is the 5-year average PE Ratio for Adimmune Corporation (4142.TW)?

How does the current PE Ratio for Adimmune Corporation (4142.TW) compare to its historical average?